13.07.2015 Views

Biochemistry/Molecular Biology - ARVO

Biochemistry/Molecular Biology - ARVO

Biochemistry/Molecular Biology - ARVO

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Biochemistry</strong>/<strong>Molecular</strong> <strong>Biology</strong>dysfunction and possible mechanisms.Results: We have reported that there was a significant loss of RGCsat 2 and 4 weeks (15.26±1.57% and 22.35±2.01%) after EVC. Here,we found that the number of RGCs in the EVC- eyes was32.3±1.24% (p< 0.01) and 41.7±2.26% (p< 0.01) lower than in thecontralateral control eyes at 2, and 6 months, indicating theprogressive RGCs loss in the EVC-eyes even after IOP elevationreversal. mtDNA damage and mutations occurred as early as 2 weekafter EVC and continued to increase in the EVC-RGCs even whenthe IOP elevation return to normal and up to 17.8-folds than thecontrol at 6 months. mtDNA copies of RGC continued to decrease(by49% at 6 months compared to control) and mtDNA repair enzymedecreased during all the observation period. ATP production rate ofmitochondria in RGC was reduced by 47% and ROS increased by38% at 6 months after EVC. In vitro results shown that pressureresulted in mtDNA damage, mtDNA copies decreased, expression ofmtDNA repair enzyme decreased, mitochondrial membrane potentialdecreased and eventually cell death. Interestingly, we foundmitochondrial fission was induced as early as 2h pressure-treated andfission itself leaded to mtDNA abnormalities.Conclusions: Progressive RGCs loss in glaucomatous rat model evenafter IOP elevation reversal. Accumulated increase of mtDNAdamage contributed to the progressive loss of RGCs in theglaucomatous model. Pressure induced mitochondria abnormality atleast partly by inhibited mitochondria fusion.Commercial Relationships: Jihong Wu, None; Shenghai Zhang,NoneSupport: National Natural Science Foundation:81170839,81070726.Shanghai Natural Science foundation:11ZR1405800Program Number: 285 Poster Board Number: D0234Presentation Time: 8:30 AM - 10:15 AMConditional mutant analysis of Dnmts in murine retinal ganglioncellsRaymond Enke 1 , Zhiyong Yang 1 , William W. Hauswirth 2 , Sanford L.Boye 2 , Vince Chiodo 2 , Donald J. Zack 1 , Shannath L. Merbs 1 .1 Ophthalmology, Johns Hopkins University, Baltimore, MD;2 Ophthalmology, University of Florida, Gainesville, FL.Purpose: We hypothesize that epigenetic mechanisms may modulatethe onset and progression of disease in the retina. As a prelude tostudying the role of DNA methylation in glaucoma and optic nervedegeneration, we set out to determine the expression pattern of DNAmethyltransferase (Dnmt) enzymes in mature murine retinal ganglioncells (RGCs). We also use conditional Dnmt mutant lines todemonstrate RGC survival following optic nerve crush.Methods: Eyes from adult wt mice were fixed in 4% PFA,equilibrated in a sucrose gradient, and cryopreserved. Retinal crosssections were cut and used for immunohistochemical (IHC) analysisof Dnmts. Conditional Dnmt1, Dnmt3a, and Dnmt3b mutants werecreated by intravitreally injecting an adeno-associated virus serotype2 (AAV2) encoding Cre recombinase into transgenic mouse linesharboring lox P sites in each respective allele. Optic nerve crush wasperformed in adult mice to induce RGC degeneration. For RGCviability analysis, eyecups were fixed in 4% PFA and used for wholemount IHC quantification of Brn3 and Tuj1. Corresponding opticnerve cross sections were also stained for phosphorylatedneurofilament (pNF).Results: IHC analysis of the adult mouse retina demonstrated thatDnmt1 and Dnmt3b are expressed in postmitotic RGCs whileDnmt3a expression is limited to amacrine cells in the ganglion celllayer (GCL) of the retina. Intravitreal delivery of AAV2-Cre resultsin efficient transduction of the mouse GCL cells and proves to be aneffective technique for producing conditional Dnmt mutant mice.Dnmt1 mutant RGCs were partially protected from degenerationfollowing optic nerve crush. Surviving Dnmt1 mutant RGCs alsodisplayed more persistent expression of Brn3 following optic nervecrush compared to controls.Conclusions: Expression of Dnmt1 and Dnmt3b in postmitoticRGCs suggests that DNA methylation may be involved in RGChomeostasis. Our current experiments further address this question byassaying the role of Dnmts in RGC survival following optic nerveinjury. A conditional mutation in Dnmt1 imparts partial protectionagainst RGC degeneration following optic nerve crush. This findingindicates that DNA methylation may be an important epigeneticsignal in response to optic neuropathy. Ongoing analysis willdetermine if Dnmt3b conditional mutants also have improved RGCviability following optic nerve crush.Commercial Relationships: Raymond Enke, None; ZhiyongYang, None; William W. Hauswirth, AGTC (I), Bionic Sight (I),AGTC (C), Syncona (C), RetroSense (C); Sanford L. Boye,PCT/US2012/062478 (P); Vince Chiodo, None; Donald J. Zack,Alcon (C), Merck (F), Allergan (C); Shannath L. Merbs, NoneSupport: American Health Assistance Foundation NationalGlaucoma Research Grant G2012033Program Number: 286 Poster Board Number: D0235Presentation Time: 8:30 AM - 10:15 AMAdenosine triphosphate (ATP) Signaling Pathways Trigger GlialActivation in the Mouse RetinaCaitlin E. Mac Nair 1, 2 , Cassandra Schlamp 2 , Robert W. Nickells 2 .1 Cellular and <strong>Molecular</strong> Pathology Graduate Program, Univeristy ofWisconsin, Madison, WI; 2 Ophthalmology and Visual Sciences,Univeristy of Wisconsin, Madison, WI.Purpose: Optic nerve injury causes RGC death and activation of theretinal macroglia and microglia. Bax-deficient RGCs are resistant tothis acute injury and display an attenuated glial activation response,indicating a relationship between cell death and glial activation.Several studies suggest that injured neurons release ATP as a distresssignal, and we investigated the potential role of ATP in triggeringglial activation, the consequence of which may lead to cytokineproduction that damages additional ganglion cells.Methods: Wild type mice were intravitreally injected with 1μl of a250μM ATP receptor agonist, either ATPγS or BzATP, and mRNAand protein levels of glial activation markers (GFAP for macrogliaand AIF1 for microglia) were monitored by qPCR andimmunofluorescence. RGC gene markers Thy1, Nrn1, and Sncg werealso monitored by qPCR. Additional experiments will include Baxdeficientmice injected with either BzATP or ATPγS, and wild typemice treated with an ATP receptor antagonist, either oxATP orPPADS, to inhibit ATP signaling from crush injury. The effects onglial activation and RGC survival will be reported.Results: Bax-deficient RGCs were completely resistant to optic nervecrush and displayed an attenuated macroglial and microglialactivation response, suggesting that cell death is required for glialactivation. A single intravitreal injection of BzATP, a specific P2X 7receptor agonist, caused a significant spike in macroglial activationby 24 hours with prominent labeling in the Müller cells. By 48 hoursmacroglial activation returned to basal levels and remainedunchanged by 72 hours. Contrary, macroglial activation by the broadspectrum P2X receptor agonist, ATPγS, showed a moderate increaseat 24 hours above vehicle-injected eyes but continued to rise at 48and 72 hours, with strong labeling of the Müller cells by 72 hours. Adecline in RGC gene markers, indicative of RGC damage, was alsoapparent at 72 hours in ATPγS-injected eyes. Microglial activationwas not greatly affected by either treatment.Conclusions: These results indicate that ATP may contribute to©2013, Copyright by the Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Go to iovs.org to access the version of record. For permissionto reproduce any abstract, contact the <strong>ARVO</strong> Office at arvo@arvo.org.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!